(Q27259663)
Statements
571.351±0 dalton
1 reference
475-00-3 (English)
14 October 2016
C₃₃H₄₉NO₇
1 reference
475-00-3 (English)
14 October 2016
CC1CC(C(NC1)C(C)C2=C(C3=C(C=C2)C4CC=C5CC(CCC5(C4C3)C)OC6C(C(C(C(O6)CO)O)O)O)C)O
1 reference
475-00-3 (English)
14 October 2016
C[C@H]1C[C@H]([C@@H](NC1)[C@@H](C)C2=C(C3=C(C=C2)[C@@H]4CC=C5C[C@H](CC[C@@]5([C@H]4C3)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O
1 reference
475-00-3 (English)
14 October 2016
Identifiers
1 reference
475-00-3 (English)
14 October 2016
1 reference
475-00-3 (English)
14 October 2016
2 references
veratrosine (English)
14 October 2016
1 reference
(3beta,23R)-23-Hydroxy-14,15,16,17-tetradehydroveratraman-3-yl beta-D-glucopyranoside (English)
14 October 2016
2 references
475-00-3 (English)
14 October 2016
1 reference
28 October 2019
VERATROSINE (English)
10 May 2021
2 references
veratrosine (English)
14 October 2016